CR1 and Alzheimer disease: Genome-wide association studies (GWAS) have repeatedly associated single nucleotide polymorphisms (SNPs) in genes encoding complement regulators clusterin (CLU) and complement receptor 1 (CR1) with risk of late-onset AD [1–4].